Abstract
Background Patients with unrecognised colonisation with multi-drug resistant Gram-negative bacteria (MDRGNB) constitute a reservoir of organisms that can precede invasive disease and potentially be transmitted to other patients. A large percentage of patients colonised with these resistant bacteria are not recognised by clinical cultures but are only detected by performing surveillance cultures. 1 Aims To validate an active surveillance screening method to detect MDRGNB. Methods An agar-based method was trialled to detect MDRGNB. The media was tested against known susceptible and resistant organisms, mixed cultures, and clinical urine and rectal swab specimens. A low-risk ethics application was obtained. Results A selection of different media was used with each testing isolate: MacConkey agar (MCA) with gentamicin 8 mg/L, MCA with ciprofloxacin 2 mg/L, MCA with ceftazidime 2 mg/L and ESBL CHROMagar1. MCA without antibiotic addition was used as a control. The media was tested across 50 different specimens. Discussion We have demonstrated a reliable and practical method to screen for MDRGNB. This methodology can be utilised for an active surveillance study to establish colonisation rates with MDRGNB.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.